14th Annual Meeting | Update on Osteoporosis and Skeletal Health 2019

03/04/2019 9:13 PMHealth Education Center Fontaine Auditorium 400 Hawthorne Oakland, CA, 94609


Downloadable PDF brochure


Ticket Type Price Cart
Allied Health/Residents/Fellows/Nurses $50
Buy Now
Physicians $75
Buy Now



AGENDA

7:30-8:00 AM Registration and Continental Breakfast

8:00-8:05
Introduction  |  Elliott N. Schwartz, MD, Program Moderator

8:05-8:50
Anabolic Therapies for Osteoporosis  |  Michael McClung, MD

8:50-9:35
Trabecular Bone Score (TBS)  |  Didier Hans, Ph.D., MBA

9:35-10:20
Update on Nephrolithiasis  |  
John R. Asplin, MD

10:20-10:40 Break

10:40-11:25
Surrogates for Fracture Endpoints: Bone Mineral Density and Bone Turnover Markers; A Study by the Foundation for the National Institutes of Health (FNIH)  |  
Douglas Bauer, MD

11:25-12:10
What the Primary Care Provider Should Know About Bisphosphonate Therapy  |  
Elliott N. Schwartz, MD

12:10-12:30 Morning Session Panel Q&A

12:30-1:15 PM Lunch with the Faculty

1:15-2:00
Genetic Markers for Osteoporosis and Musculoskeletal Injuries  |  Stuart K. Kim, PhD

2:00-2:45
FGF-23 and Klotho  |  Susan M. Ott, MD

2:45-3:00 Break

3:00-3:45
Glucocorticoid-induced Osteoporosis: An Update  |  Michael Maricic, MD

3:45-4:30
Update on denosumab  |  
Michael McClung, MD

4:30-5:15
The Treatment Gap and How to Fix It  |  Douglas Bauer, MD

5:15-5:25 Afternoon Session Panel Q&A

5:25-5:30 Conclusion and Evaluation

 


LEARNING OBJECTIVES

After this meeting, attendees will be able to:

  1. Describe important new information on medications for osteoporosis.
  2. Discuss the role of genetic screens to predict fracture risk.
  3. Relate the role of FGF-23 and Klotho in the etiology of metabolic bone disease.
  4. Recognize the importance of glucocorticoid-induced osteoporosis and its treatment.
  5. Identify the role and measurement of bone quality in the evaluation of bone strength.
  6. Define the work-up of nephrolithiasis and its significance in metabolic bone disease.

Physician Accreditation:  The Northern California Institute for Bone Health, Inc. is the provider for continuing medical education for physicians and allied health professionals.


ACCREDITATION

This Live activity, UPDATE ON OSTEOPOROSIS AND SKELETAL HEALTH 2019, with a beginning date of 5/31/2019, has been reviewed and is acceptable for up to 8.0 Elective credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There are no refunds for this event.

Ticket Type Price Cart
Allied Health/Residents/Fellows/Nurses $50
Add to Cart
Physicians $75
Add to Cart
 
 
 
 

Sign up for a FREE newsletter.

* Get breaking medical news and clinical perspectives on Osteoporosis & Skeletal health.
* Unlimited access to the Annual Meeting medical education course videos.

The Northern California Institute for Bone Health, Inc., is dedicated to detection of bone loss and improvement in treatment utilizing bone density testing, clinical research and education of physicians, allied health professionals and the general public.  Join us!